日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and characterization of AD-214, an anti-CXCR4 i-body-Fc fusion for the treatment of idiopathic pulmonary fibrosis.

AD-214(一种用于治疗特发性肺纤维化的抗CXCR4 i-body-Fc融合蛋白)的开发和表征

Lynch Jason P, Organ Louise, Tomusange Khamis, Kowalczyk Lukasz, Hartman Dallas J, Tester Angus, Hosking Chris, Foley Michael

Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques

恒河猴早期非加速型猴-人免疫缺陷病毒感染期间的中枢神经系统炎症和感染

Hsu, Denise C; Sunyakumthorn, Piyanate; Wegner, Matthew; Schuetz, Alexandra; Silsorn, Decha; Estes, Jacob D; Deleage, Claire; Tomusange, Khamis; Lakhashe, Samir K; Ruprecht, Ruth M; Lombardini, Eric; Im-Erbsin, Rawiwan; Kuncharin, Yanin; Phuang-Ngern, Yuwadee; Inthawong, Dutsadee; Chuenarom, Weerawan; Burke, Robin; Robb, Merlin L; Ndhlovu, Lishomwa C; Ananworanich, Jintanat; Valcour, Victor; O'Connell, Robert J; Spudich, Serena; Michael, Nelson L; Vasan, Sandhya

Anti-HIV IgM protects against mucosal SHIV transmission

抗HIV IgM可预防黏膜HIV传播

Gong, Siqi; Tomusange, Khamis; Kulkarni, Viraj; Adeniji, Opeyemi S; Lakhashe, Samir K; Hariraju, Dinesh; Strickland, Amanda; Plake, Elizabeth; Frost, Patrice A; Ratcliffe, Sarah J; Wang, Liping; Lafer, Eileen M; Ruprecht, Ruth M

Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses

黏膜接种重组活鼻病毒疫苗,随后进行皮内注射DNA,可诱导产生强效且具有保护作用的HIV特异性免疫反应。

Tomusange, Khamis; Wijesundara, Danushka; Gummow, Jason; Wesselingh, Steve; Suhrbier, Andreas; Gowans, Eric J; Grubor-Bauk, Branka

A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice

一种由DNA疫苗编码的HIV-Tat/C4结合蛋白嵌合体具有高度免疫原性,并可在小鼠中诱发急性EcoHIV感染。

Tomusange, Khamis; Wijesundara, Danushka; Gummow, Jason; Garrod, Tamsin; Li, Yanrui; Gray, Lachlan; Churchill, Melissa; Grubor-Bauk, Branka; Gowans, Eric J